These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 7873529)

  • 1. Interaction of histidine-proline-rich glycoprotein with plasminogen: effect of ligands, pH, ionic strength, and chemical modification.
    Saez CT; Jansen GJ; Smith A; Morgan WT
    Biochemistry; 1995 Feb; 34(8):2496-503. PubMed ID: 7873529
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Histidine-proline-rich glycoprotein as a plasma pH sensor. Modulation of its interaction with glycosaminoglycans by ph and metals.
    Borza DB; Morgan WT
    J Biol Chem; 1998 Mar; 273(10):5493-9. PubMed ID: 9488672
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of histidine-proline-rich glycoprotein on plasminogen activation in solution and on surfaces.
    Borza DB; Shipulina NV; Morgan WT
    Blood Coagul Fibrinolysis; 2004 Oct; 15(8):663-72. PubMed ID: 15613921
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Acceleration of plasminogen activation by tissue plasminogen activator on surface-bound histidine-proline-rich glycoprotein.
    Borza DB; Morgan WT
    J Biol Chem; 1997 Feb; 272(9):5718-26. PubMed ID: 9102401
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Domain structure and conformation of histidine-proline-rich glycoprotein.
    Borza DB; Tatum FM; Morgan WT
    Biochemistry; 1996 Feb; 35(6):1925-34. PubMed ID: 8639676
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization of the zinc-binding site of the histidine-proline-rich glycoprotein associated with rabbit skeletal muscle AMP deaminase.
    Mangani S; Meyer-Klaucke W; Moir AJ; Ranieri-Raggi M; Martini D; Raggi A
    J Biol Chem; 2003 Jan; 278(5):3176-84. PubMed ID: 12441349
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Platelet thrombospondin forms a trimolecular complex with plasminogen and histidine-rich glycoprotein.
    Silverstein RL; Leung LL; Harpel PC; Nachman RL
    J Clin Invest; 1985 Jun; 75(6):2065-73. PubMed ID: 4008652
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Histidine-proline rich glycoprotein (HPRG) binds and transduces anti-angiogenic signals through cell surface tropomyosin on endothelial cells.
    Guan X; Juarez JC; Qi X; Shipulina NV; Shaw DE; Morgan WT; McCrae KR; Mazar AP; Doñate F
    Thromb Haemost; 2004 Aug; 92(2):403-12. PubMed ID: 15269838
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Histidine-proline-rich glycoprotein has potent antiangiogenic activity mediated through the histidine-proline-rich domain.
    Juarez JC; Guan X; Shipulina NV; Plunkett ML; Parry GC; Shaw DE; Zhang JC; Rabbani SA; McCrae KR; Mazar AP; Morgan WT; Doñate F
    Cancer Res; 2002 Sep; 62(18):5344-50. PubMed ID: 12235005
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Further characterization of the interaction of histidine-rich glycoprotein with heparin: evidence for the binding of two molecules of histidine-rich glycoprotein by high molecular weight heparin and for the involvement of histidine residues in heparin binding.
    Burch MK; Blackburn MN; Morgan WT
    Biochemistry; 1987 Nov; 26(23):7477-82. PubMed ID: 3427089
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Isolation by zinc-affinity chromatography of the histidine-proline-rich-glycoprotein molecule associated with rabbit skeletal muscle AMP deaminase. Evidence that the formation of a protein-protein complex between the catalytic subunit and the novel component is critical for the stability of the enzyme.
    Ranieri-Raggi M; Martini D; Sabbatini AR; Moir AJ; Raggi A
    Biochim Biophys Acta; 2003 Jan; 1645(1):81-8. PubMed ID: 12535614
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Structure-function relationships in mammalian histidine-proline-rich glycoprotein.
    Ronca F; Raggi A
    Biochimie; 2015 Nov; 118():207-20. PubMed ID: 26409900
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Complex formation of platelet thrombospondin with plasminogen. Modulation of activation by tissue activator.
    Silverstein RL; Leung LL; Harpel PC; Nachman RL
    J Clin Invest; 1984 Nov; 74(5):1625-33. PubMed ID: 6438154
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association of purified skeletal-muscle AMP deaminase with a histidine-proline-rich-glycoprotein-like molecule.
    Ranieri-Raggi M; Montali U; Ronca F; Sabbatini A; Brown PE; Moir AJ; Raggi A
    Biochem J; 1997 Sep; 326 ( Pt 3)(Pt 3):641-8. PubMed ID: 9307011
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mechanism of the synergistic effect between oversulfated chondroitin-6-sulfate and lysine or 6-aminohexanoic acid in enhancing the in-vitro activation of glutamic plasminogen by tissue plasminogen activator or urokinase.
    Kouemo S; McMillan E; Doctor V
    Blood Coagul Fibrinolysis; 2010 Jul; 21(5):425-30. PubMed ID: 20445443
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Histidine-proline-rich glycoprotein binding to platelets mediated by transition metals.
    Horne MK; Merryman PK; Cullinane AM
    Thromb Haemost; 2001 May; 85(5):890-5. PubMed ID: 11372684
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Peptides derived from the histidine-proline domain of the histidine-proline-rich glycoprotein bind to tropomyosin and have antiangiogenic and antitumor activities.
    Doñate F; Juarez JC; Guan X; Shipulina NV; Plunkett ML; Tel-Tsur Z; Shaw DE; Morgan WT; Mazar AP
    Cancer Res; 2004 Aug; 64(16):5812-7. PubMed ID: 15313924
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Purification of rabbit serum histidine-proline-rich glycoprotein via preparative gel electrophoresis and characterization of its glycosylation patterns.
    Weyrauch AK; Jakob M; Schierhorn A; Klösgen RB; Hinderberger D
    PLoS One; 2017; 12(9):e0184968. PubMed ID: 28934288
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The role of histidine-proline-rich glycoprotein as zinc chaperone for skeletal muscle AMP deaminase.
    Ranieri-Raggi M; Moir AJ; Raggi A
    Biomolecules; 2014 May; 4(2):474-97. PubMed ID: 24970226
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The solution phase interaction between apolipoprotein(a) and plasminogen inhibits the binding of plasminogen to a plasmin-modified fibrinogen surface.
    Sangrar W; Gabel BR; Boffa MB; Walker JB; Hancock MA; Marcovina SM; Horrevoets AJ; Nesheim ME; Koschinsky ML
    Biochemistry; 1997 Aug; 36(34):10353-63. PubMed ID: 9265615
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.